FUM Stock Overview
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Futura Medical plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.40 |
52 Week High | UK£0.67 |
52 Week Low | UK£0.23 |
Beta | 1.28 |
1 Month Change | 9.67% |
3 Month Change | 3.12% |
1 Year Change | -5.92% |
3 Year Change | -15.53% |
5 Year Change | 82.11% |
Change since IPO | -44.48% |
Recent News & Updates
We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth
Apr 17Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation
Jan 05Recent updates
We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth
Apr 17Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation
Jan 05Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?
Jul 28We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully
Mar 18We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate
Sep 25Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation
May 10We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow
Jan 10What We Learned About Futura Medical's (LON:FUM) CEO Compensation
Dec 21Shareholder Returns
FUM | GB Pharmaceuticals | GB Market | |
---|---|---|---|
7D | 7.9% | 3.1% | 2.5% |
1Y | -5.9% | 8.0% | 5.8% |
Return vs Industry: FUM underperformed the UK Pharmaceuticals industry which returned 8% over the past year.
Return vs Market: FUM underperformed the UK Market which returned 5.8% over the past year.
Price Volatility
FUM volatility | |
---|---|
FUM Average Weekly Movement | 8.8% |
Pharmaceuticals Industry Average Movement | 8.1% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: FUM's share price has been volatile over the past 3 months.
Volatility Over Time: FUM's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 12 | James Barder | www.futuramedical.com |
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Futura Medical plc Fundamentals Summary
FUM fundamental statistics | |
---|---|
Market cap | UK£119.68m |
Earnings (TTM) | -UK£6.51m |
Revenue (TTM) | UK£3.10m |
38.6x
P/S Ratio-18.4x
P/E RatioIs FUM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FUM income statement (TTM) | |
---|---|
Revenue | UK£3.10m |
Cost of Revenue | UK£1.33m |
Gross Profit | UK£1.77m |
Other Expenses | UK£8.29m |
Earnings | -UK£6.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.022 |
Gross Margin | 57.22% |
Net Profit Margin | -210.03% |
Debt/Equity Ratio | 0% |
How did FUM perform over the long term?
See historical performance and comparison